RT Journal Article
SR Electronic
T1 Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil
JF British Journal of Sports Medicine
JO Br J Sports Med
FD BMJ Publishing Group Ltd and British Association of Sport and Exercise Medicine
SP 614
OP 622
DO 10.1136/bjsports-2015-094762
VO 49
IS 9
A1 Norbert Baume
A1 Nicolas Jan
A1 Caroline Emery
A1 Béatrice Mandanis
A1 Carine Schweizer
A1 Sylvain Giraud
A1 Nicolas Leuenberger
A1 François Marclay
A1 Raul Nicoli
A1 Laurent Perrenoud
A1 Neil Robinson
A1 Jiri Dvorak
A1 Martial Saugy
YR 2015
UL http://bjsm.bmj.com/content/49/9/614.abstract
AB Background The FIFA has implemented an important antidoping programme for the 2014 FIFA World Cup. Aim To perform the analyses before and during the World Cup with biological monitoring of blood and urine samples. Methods All qualified players from the 32 teams participating in the World Cup were tested out-of-competition. During the World Cup, 2–8 players per match were tested. Over 1000 samples were collected in total and analysed in the WADA accredited Laboratory of Lausanne. Results The quality of the analyses was at the required level as described in the WADA technical documents. The urinary steroid profiles of the players were stable and consistent with previously published papers on football players. During the competition, amphetamine was detected in a sample collected on a player who had a therapeutic use exemption for attention deficit hyperactivity disorder. The blood passport data showed no significant difference in haemoglobin values between out-of-competition and postmatch samples. Conclusions Logistical issues linked to biological samples collection, and the overseas shipment during the World Cup did not impair the quality of the analyses, especially when used as the biological passport of football players.